top of page

         Weight loss program

The drugs, taken once a week by injection, simulate naturally produced hormones that curb appetite and slow digestion, creating longer-lasting satiety. A healthy diet and exercise also assist with weight loss.

According to Healthline, written by David Mills on January 21, 2025, and fact-checked by Jill Seladi-Schulman, Ph.D.

Mounjaro and Zepbound contain the active ingredient tirzepatide. Mounjaro is approved to treat type 2 diabetes, while Zepbound has been approved for weight management treatment. “GLP-1 meds represent the first class of medications that offer effective weight-loss options for patients,” she said. “In addition, randomized clinical trials show that the GLP-1 meds are associated with significant benefits, including decreasing risk for cardiovascular disease, kidney disease, sleep apnea, and arthritis. The future is bright for GLP-1 drugs.” (https://www.healthline.com/health-news/glp-1-drugs-benefits-risks-health-outcomes)

Service Description:

  1. Comprehensive Medical Evaluation

    • Reviewed detailed weight history

    • Assessed metabolic history

    • Considered lifestyle factors

  2. Initiation of GLP-1 Therapy (Tirzepatide/Mounjaroor Zepbound

    • Medication

    • Patient education: Injection technique, storage, and rotation sites (thigh, back of arm)

  3. Lifestyle & Behavioral Counseling

    • Developed realistic, structured exercise plan (10–15 minutes walking, strength training with alternating upper/lower body, total 25 minutes/session)

    • Encouraged a gradual increase in physical activity based on energy and fibromyalgia symptoms

  4. Nutritional Support

    • Provided food journal and 

    • Placed referral to registered dietitian for personalized meal planning

  5. Supplementation & Adjunctive Therapies

    • Initiated Magnesium Glycinate 100 mg, increasing to 200 mg in week 2

    • Discussed the importance of hydration and balanced electrolytes during GLP-1 therapy

  6. Monitoring and Follow-Up Plan

    • Monthly follow-ups to monitor progress, titrate medication, and review labs

Expected Patient Benefits:

  • Sustainable Weight Loss: GLP-1s reduce appetite

  • Metabolic Improvement: Lower insulin resistance, support glucose stabilization (prediabetes management)

  • Improved Energy: Potential secondary benefit from weight reduction and better glucose control

  • Support for Physical Activity: Structured, manageable reintroduction to movement that supports long-term fitness goals

  • Mental & Emotional Health: Renewed motivation with structured plan and clinical support; 

The drugs, taken once a week by injection, simulate naturally produced hormones that curb appetite and slow digestion, creating longer-lasting satiety. A healthy diet and exercise also assist with weight loss.

According to Healthline, written by David Mills on January 21, 2025, and fact-checked by Jill Seladi-Schulman, Ph.D.

Mounjaro and Zepbound contain the active ingredient tirzepatide. Mounjaro is approved to treat type 2 diabetes, while Zepbound has been approved for weight management treatment. “GLP-1 meds represent the first class of medications that offer effective weight-loss options for patients,” she said. “In addition, randomized clinical trials show that the GLP-1 meds are associated with significant benefits, including decreasing risk for cardiovascular disease, kidney disease, sleep apnea, and arthritis. The future is bright for GLP-1 drugs.” (https://www.healthline.com/health-news/glp-1-drugs-benefits-risks-health-outcomes)

Citrus Fruits
bottom of page